| Bioactivity | Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia[1][2]. | ||||||||||||
| Invitro | The in vitro activities of Moxifloxacin and Amoxicillin are compared by time-kill curve and inhibition of intracellular growth experiments by using a model of bone marrow-derived mouse macrophages infected by L. monocytogenes EGDe. Moxifloxacin acts much more rapidly, beginning to exert its effects in the first 3 h and achieving complete broth sterilization within 24 h of incubation. Moxifloxacin appears to have a protective effect against macrophage lysis, as many cells are still viable after 24 h of incubation[3]. | ||||||||||||
| Name | Moxifloxacin | ||||||||||||
| CAS | 151096-09-2 | ||||||||||||
| Formula | C21H24FN3O4 | ||||||||||||
| Molar Mass | 401.43 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Moxifloxacin
CAS: 151096-09-2 F: C21H24FN3O4 W: 401.43
Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis,
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.